"Today’s HTA roundtable was a constructive first step. High level, thought-provoking presentations were made, which should initiate a series of further more focused roundtables," said Medicines Australia CEO Liz de Somer. …
Latest Video
New Stories
-
La Trobe launches REACH program to fight antimicrobial resistance
May 6, 2026 - - Latest News -
If the imperative is international comparison, why limit it to these definitions?
May 5, 2026 - - Latest News -
Therapy funded three years after the 'clunky' and 'preventable deaths' admission
May 5, 2026 - - Latest News -
Time to make this 'targeted' consultation a little less targeted
May 5, 2026 - - Latest News -
Australia approves first in class therapy for chronic graft versus host disease
May 5, 2026 - - Latest News -
Lilly therapy approved in Australia as first non-covalent BTK inhibitor for common blood cancer
May 5, 2026 - - Latest News -
Medicines Australia calls for transparency, highlighting the risk of bias
May 5, 2026 - - Latest News